Indirect effect of insulin to suppress endogenous glucose production is dominant, even with hyperglucagonemia.
Suppression of endogenous glucose production (EGP) is one of insulin's primary metabolic effects and failure of this action is a major contributor to fasting hyperglycemia of type 2 diabetes mellitus. Classically, insulin was thought to suppress the liver directly, via hyperinsulinemia in the portal...
Enregistré dans:
| Publié dans: | J Clin Invest |
|---|---|
| Auteurs principaux: | , , , , |
| Format: | Artigo |
| Langue: | Inglês |
| Publié: |
American Society for Clinical Investigation
1997
|
| Sujets: | |
| Accès en ligne: | https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC508525/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/9399959/ https://ncbi.nlm.nih.govhttps://doi.org/10.1172/JCI119867 |
| Tags: |
Pas de tags, Soyez le premier à ajouter un tag!
|
